OUR TARGETS

TARGETS

Our commitment to innovation and excellence drives us to explore new frontiers in medicine, ensuring that we deliver the most advanced and effective treatments to improve lives globally.

ONCOLOGY

Our robust oncology portfolio comprises multiple theragnostic agents to enable precise diagnosis and treatment across various cancer types. These technologies are engineered to enhance patient outcomes through early and accurate cancer detection, as well as personalized therapeutic plans tailored to each patient’s unique needs. By transforming detection and treatment, we aim to significantly improve survival rates and quality of life for cancer patients

RARE DISEASES

Our rare disease portfolio features diagnostic agents intended to address a variety of rare and disabling childhood conditions. These novel radiopharmaceuticals are engineered to facilitate earlier and more precise diagnosis, as well as tailored treatment plans that can dramatically improve quality of life for affected children and their families. By targeting critical unmet needs, we aim to transform the standard-of-care for numerous rare pediatric diseases.

INFECTIOUS DISEASES

Our infectious disease pipeline features diagnostic and therapeutic radiopharmaceuticals to facilitate rapid, precise diagnosis of various pathogenic infections, as well as personalized treatments tailored to each patient. These technologies are especially critical for emerging infectious diseases and bioterrorism threats. By transforming detection and treatment, we aim to curb outbreaks and save lives through accurate, prompt diagnosis and tailored patient care.

BIOMEDICAL COUNTERMEASEURES

Our biomedical countermeasures pipeline comprises specialized drugs to bolster medical countermeasures against biological, radiological and nuclear dangers. These technologies are engineered to effectively treat acute radiation syndrome and safeguard armed forces and civilians from radiological exposure and contamination. By transforming preparedness and response, we aim to mitigate fallout and mortality from weapons of mass destruction.